Imidazoline receptor proteins are regulated in platelet-precursor MEG-01 cells by agonists and antagonists

Journal of Psychiatric Research

Volumn 32, Issue 2, 1998, Pages 65-79

  Ivanov, T R ^a   Feng, Y ^a   Wang, H ^b   Regunathan, S ^b   Reis, D J ^b   Chikkala, D N ^a,c   Gupta, P ^a,c   Jones, J C ^a   Piletz, J E ^a  

^a UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

^c METROHEALTH MEDICAL CENTER   (United States)

Author keywords

Adrenal chromaffin cells; Depression; Down regulation; Idazoxan; Imidazoline receptor; Immunoreactivity; MEG 01; Megakaryocytes; Monoamine oxidase; Moxonidine; Norepinephrine; P iodoclonidine; Platelets

Indexed keywords

AGMATINE; IDAZOXAN; IMIDAZOLINE I1 RECEPTOR; MOXONIDINE; YOHIMBINE;

ARTICLE; CELL LINE; CELL MEMBRANE; CHROMAFFIN CELL; HUMAN; HUMAN CELL; IMMUNOBLOTTING; MEGAKARYOCYTE; PRIORITY JOURNAL; REGULATORY MECHANISM;

AGMATINE; ANIMALS; BLOOD PLATELETS; CATTLE; HUMANS; IDAZOXAN; IMIDAZOLES; NOREPINEPHRINE; RECEPTORS, DRUG; TUMOR CELLS, CULTURED; UP-REGULATION; YOHIMBINE;

EID: 0032029289     PISSN: 00223956     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-3956(98)00006-5     Document Type: Article

References (47)

1. 2 imidazoline-preferring receptors. British Journal of Pharmacology 1995;114:837-45.
2. Bennai F, Greney H, Vonthron C, Bousquet P, Dontenwill, M. Polyclonal anti-idiotypic antibodies to idazoxan and their interaction with human brain imidazoline binding sites. European Journal of Pharmacology 1996;306:211-8.
3. Bousquet P, Feldman J, Bloch R, Schwartz J. Central cardiovascular effects of alpha-adrenergic drugs; differences between catecholamines and imidazolines. Journal of Pharmacology & Experimental Therapeutics 1984;230:232-6.
4. Bricca G, Dontenwill M, Molines A, Feldman J, Belcourt A, Bousquet P, The imidazoline preferring receptor: binding studies in bovine, rat and human brainstem. European Journal of Pharmacology 1989;162:1-9.
5. Chen K, Wu HF, Shih J. The deduced amino acid sequence of human platelet and frontal cortex monoamine oxidase B are identical. Journal of Neurochemistry 1993;61:187-90.
6. Corash L. Platelet heterogeneity: relevance to the use of platelets to study psychiatric disorders. Schizophrenia Bulletin 1980; 6:254-8.
7. Denney RM, Fritz RR, Patel NT, Abell CW. Human liver MAO-A and MAO-B separated by immunoaffinity chromatography with MAO-B-specific monoclonal antibody. Science 1982;215:1400-3.
8. Ernsberger P, Giulioano R, Willette RN, Reis, DJ. Role of imidazole receptors in the vasodepressor response to clonidine analogs in the rostral ventral medulla. Journal of Pharmacology & Experimental Therapeutics 1990;253:408-18.
9. 2-adrenoceptors in the ventrolateral medulla. European Journal of Pharmacology 1987;134:1-13.
10. 1-imidazoline sites. In: Reis DJ, Bousquet P, Parini A, editors, The Imidazoline Receptor: Pharmacology, Functions, Ligands, and Relevance to Biology and Medicine. p. 163-8), Vol 763,. Annals of New York Academy of Sciences: New York 1995.
11. Escriba PV, Ozaita A, Miralles A, Reis DJ, Garcia-Sevilla JA. Molecular characterization and isolation of a 45-kilodalton imidazoline receptor protein from the rat brain. Molecular Brain Research 1995;32:187-96.
12. Escriba PV, Sastre M, Wang H, Regunathan S, Reis DJ, Garcia-Sevilla JA. Immunodetection of putative imidazoline receptor proteins in the human and rat brain and other tissues. Neuroscience Letters 1994;178:81-4.
13. Garcia-Sevilla JA, Escriba PV, Sastre M, Walzer C, Busquets X, Jaquet G, Reis DJ, Guimon J. Immunodetection and quantitation of imidazoline receptor proteins in platelets of patients with major depression and in brain of suicide victims. Archives of General Psychiatry 1996;53:803-10.
14. 3H]-idazoxan. Neuroscience Letters 1995;184:133-6.
15. Halaris A, Piletz J, Ivanov T, Zhu H, Madakasira S, Feng YZ, Goldman N. Platelet immunoreactivity and radioligand binding to imidazoline receptors in depression. European Neuropsychopharmacology 1996;6 Suppl 3:88.
16. Imamura N, Mtasiwa DM, Inada T, Kuramoto A, Ogura M, Saito H. Synergistic effect of recombinant human erythropoietin and phorbol diester in platelet production by the human megakaryoblastic leukemia cell line (MEG-01). American Journal of Hematology 1990a;34:77-9.
17. Imamura N, Mtasiwa D, Inada T, Kuramoto A, Ogura M, Saito H. Varied expressions of receptors on the human megakaryoblastic cell line MEG-01 by monoclonal antibodies. American Journal of Hematology 1990b;34:154-6.
18. Ivanov TR, Zhu H, Regunathan S, Reis DJ, Dontenwill M, Vonthron C, Bousquet P, Piletz JE. Detection of a novel plasma membrane protein using two imidazoline receptor antisera. Biochemical Pharmacology: 1998;55:649-655.
19. 2-adrenergic receptors from rat adrenocortical carcinoma and human blood platelets. Molecular, Cellular Biochemistry 1989;86:41-53.
20. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970;227:680-5.
21. Lanier SM, Ivkovic B, Singh I, Neumeyer JL, Bakthavachalam V. Visualization of multiple imidazoline/guanidinium-receptive sites. Journal of Biological Chemistry 1993;268:16047-51.
22. Lanier B, Raddatz R, Bakthavachalam V, Coupry I, Neumeyer JL, Lanier SM. Structural and ligand recognition properties of imidazoline binding proteins in tissues of rat and rabbit. Molecular Pharmacology 1995;48:703-10.
23. Limbird, LE. Identification of receptors using direct radioligand binding techniques. In Surface Receptors: A Short Course On Theory And Methods, Boston: Martinus Nijhoff Publishing, p. 60-96 Cell 1986
24. Lowry OH, Rosebrough NR, Farr AL, Randall RJ, Protein measurement with the Folin phenol reagent. Journal of Biological Chemistry 1951;193:265-75.
25. McPherson, GA. Analysis of radioligand binding experiments: a collection of computer programs for IBM PC. Journal of Pharmacological Methods 1985;14:213-28.
26. Michel MC, Ernsberger P. Keeping an eye on the I site: imidazoline-preferring receptors. Trends in Pharmacological Sciences 1992;13:369-70.
27. 2-adrenergic receptor-enriched membranes from human platelets: persistent association of guanine nucleotides with non-purified membranes. Biochemical Biophysical Acta 1986;854:67-76.
28. Ogura M, Morishima Y, Ohno R, Kato Y, Hirabayashi N, Nagura H, Saito H. Establishment of a novel human megakaryoblastic leukemia cell line, MEG-01, with positive Philadelphia chromosome. Blood 1985;66:1384-92.
29. 2-adrenoceptor sites plus a non-adrenergic site on human platelet plasma membranes. Biochemical Pharmacology 1991;42:569-84.
30. 1-imidazoline binding sites: relationship with catecholamines in women of reproductive age. J Psychiatric Research 1998;32:55-64.
31. 2-adrenergic receptors: implications for depression. Critical Reviews in Neurobiology 1995a;9:29-66.
32. 2-adrenergic receptors. Journal of Pharmacology & Experimental Therapeutics 1995b;272:581-7.
33. 3H-para-aminoclonidine binding to different platelet preparations. Journal of Neural Transmission 1990;82:11-29.
34. 1-imidazoline binding sites are decreased by two dissimilar antidepressant agents in depressed patients. Journal of Psychiatric Research 1996a;30:169-84.
35. 1-imidazoline binding sites are elevated in depression but not generalized anxiety disorder. Journal of Psychiatric Research 1996b;30:147-68.
36. 3H-para-aminoclonidine binding to platelet purified plasma membranes from depressed patients. Neuropsychopharmacology 1990;3:201-10.
37. Piletz JE, Sletten K. Non-adrenergic imidazoline binding sites on human platelets. Journal of Pharmacology & Experimental Therapeutics 1993;267:1493-502.
38. 2 adrenoceptor subtypes. Journal of Pharmacology Experimental Therapeutics 1996c;279:694-702.
39. Regunathan S, Youngson C, Raasch W, Wang H, Reis DJ. Imidazoline receptors and agmatine in blood vessels: a novel system inhibiting vascular smooth muscle proliferation. Journal of Pharmacology & Experimental Therapeutics 1996;276:1272-82.
40. 2-type receptors: pharmacological characterization and relationship to monamine oxidase. British Journal of Pharmacology 1993;109:625-31.
41. 1-imidazoline receptors in PC12 cells and rostral ventrolateral medulla. Brain Research 1997;749:335-9.
42. 2 with MAO-B sites. Journal of Neurochemistry 1993;61:881-9.
43. Takeuchi K, Ogura M, Saito H, Satoh M, Takeuchi M. Production of platelet-like particles by a human megakaryocytic leukemia cell line (MEG-01). Experimental Cell Research 1991;193:223-6.
44. 2-imidazoline binding sites on monoamine oxidase. Journal of Biological Chemistry 1995;270:9836-61.
45. Tesson F, Prip-Buus C, Lemoine A, Pegorier J-P, Parini A. Subcellular distribution of imidazoline-guanidinium-receptive sites in human and rabbit liver. Major localization to the mitochondrial outer membrane. Journal of Biological Chemistry 1991;266:155-60.
46. Wang H, Regunathan, S, Meeley, MP, Reis, DJ. Isolation and characterization of imidazoline receptor protein from bovine adrenal chromaffin cells. Molecular Pharmacology 1992;42:792-801.
47. Wang H, Regunathan S, Ruggiero DA, Reis DJ. Production and characterization of antibodies specific for the imidazoline receptor protein. Molicular Pharmacology 1993;43:503-15.